Arcus Biosciences reported revenue of $41.00M and net income of -$91.00M for the quarter ended Jun 2026, down 74.4% year over year. This income statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||
| Revenue | 9.46M | 354.62M | 18.00M | 27.00M | 33.00M | 34.00M | 25.00M | 29.00M | 32.00M | 14.00M | 145.00M | 39.00M | 48.00M | 26.00M | 28.00M | 160.00M | 26.00M | 33.00M | 17.00M | 41.00M | ||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 71.25M | 50.59M | 61.00M | 70.00M | 77.00M | 80.00M | 81.00M | 84.00M | 82.00M | 93.00M | 109.00M | 115.00M | 123.00M | 101.00M | 122.00M | 139.00M | 141.00M | 121.00M | 122.00M | 113.00M | ||||||||||||||||||
| Selling, General & AdministrativeSG&A | 16.34M | 23.01M | 24.00M | 26.00M | 26.00M | 28.00M | 30.00M | 28.00M | 30.00M | 29.00M | 32.00M | 30.00M | 30.00M | 28.00M | 28.00M | 29.00M | 27.00M | 26.00M | 29.00M | 24.00M | ||||||||||||||||||
| Other Operating ExpensesOther Opex | 20.00M | |||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 87.60M | 73.60M | 85.00M | 96.00M | 103.00M | 108.00M | 111.00M | 112.00M | 112.00M | 122.00M | 161.00M | 145.00M | 153.00M | 129.00M | 150.00M | 168.00M | 168.00M | 147.00M | 151.00M | 137.00M | ||||||||||||||||||
| Operating IncomeOp. Inc | -78.14M | 281.02M | -67.00M | -69.00M | -70.00M | -74.00M | -86.00M | -83.00M | -80.00M | -91.00M | -16.00M | -106.00M | -105.00M | -103.00M | -122.00M | -8.00M | -142.00M | -114.00M | -134.00M | -96.00M | ||||||||||||||||||
| EBIT | -78.14M | 281.02M | -67.00M | -69.00M | -70.00M | -74.00M | -86.00M | -83.00M | -80.00M | -91.00M | -16.00M | -106.00M | -105.00M | -103.00M | -122.00M | -8.00M | -142.00M | -114.00M | -134.00M | -96.00M | ||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 1.00M | 1.00M | 1.00M | 2.00M | 1.00M | 2.00M | 3.00M | 2.00M | 3.00M | 3.00M | ||||||||||||||||||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | ||||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.16M | 0.52M | 0.58M | 3.00M | 5.00M | 8.00M | 9.00M | 9.00M | 12.00M | 11.00M | 13.00M | 13.00M | 14.00M | 12.00M | 11.00M | 10.00M | 10.00M | 10.00M | 9.00M | 8.00M | ||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.16M | 0.52M | 0.19M | 2.00M | 5.00M | 7.00M | 8.00M | 9.00M | 11.00M | 11.00M | 12.00M | 13.00M | 13.00M | 10.00M | 10.00M | 8.00M | 7.00M | 8.00M | 6.00M | 5.00M | ||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||
| EBT | -77.97M | 281.54M | -67.00M | -67.00M | -65.00M | -67.00M | -78.00M | -74.00M | -69.00M | -80.00M | -4.00M | -93.00M | -92.00M | -93.00M | -112.00M | -135.00M | -106.00M | -128.00M | -91.00M | |||||||||||||||||||
| Tax ProvisionsTaxes | 2.00M | 1.00M | 2.00M | 1.00M | 2.00M | 1.00M | 1.00M | |||||||||||||||||||||||||||||||
| Profit After TaxPAT | -78.02M | 279.67M | -68.00M | -67.00M | -65.00M | -67.00M | -80.00M | -75.00M | -71.00M | -81.00M | -4.00M | -93.00M | -92.00M | -94.00M | -112.00M | -135.00M | -106.00M | -128.00M | -91.00M | |||||||||||||||||||
| Equity Income | ||||||||||||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -77.97M | 279.54M | -68.00M | -67.00M | -65.00M | -67.00M | -80.00M | -75.00M | -71.00M | -81.00M | -4.00M | -93.00M | -92.00M | -94.00M | -112.00M | -135.00M | -106.00M | -128.00M | -91.00M | |||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -77.97M | 279.54M | -68.00M | -67.00M | -65.00M | -67.00M | -80.00M | -75.00M | -71.00M | -81.00M | -4.00M | -93.00M | -92.00M | -94.00M | -112.00M | -135.00M | -106.00M | -128.00M | -91.00M | |||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -77.97M | 279.54M | -68.00M | -67.00M | -65.00M | -67.00M | -80.00M | -75.00M | -71.00M | -81.00M | -4.00M | -93.00M | -92.00M | -94.00M | -112.00M | -135.00M | -106.00M | -128.00M | -91.00M | |||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -77.97M | 279.54M | -68.00M | -67.00M | -65.00M | -67.00M | -80.00M | -75.00M | -71.00M | -81.00M | -4.00M | -93.00M | -92.00M | -94.00M | -112.00M | -135.00M | -106.00M | -128.00M | -91.00M | |||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -1.09 | 4.03 | -0.96 | -0.93 | -0.90 | -0.93 | -1.10 | -1.02 | -0.95 | -1.09 | -0.05 | -1.02 | -1.01 | -1.04 | -1.14 | -1.27 | -0.99 | -1.02 | -0.72 | |||||||||||||||||||
| EPS (Diluted) | -1.11 | 3.78 | -0.96 | -0.93 | -0.90 | -0.93 | -1.10 | -1.02 | -0.95 | -1.09 | -0.05 | -1.02 | -1.01 | -1.04 | -1.14 | -1.27 | -0.99 | -1.02 | -0.72 | |||||||||||||||||||
| Shares Outstanding | 71.29M | 69.35M | 71.20M | 71.80M | 72.20M | 72.00M | 73.00M | 73.20M | 74.60M | 74.00M | 86.20M | 91.10M | 91.40M | 90.10M | 98.40M | 106.10M | 106.50M | 107.40M | 125.40M | 126.10M | ||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 70.11M | 74.00M | 71.20M | 71.80M | 72.20M | 72.00M | 73.00M | 73.20M | 74.60M | 74.00M | 86.20M | 91.10M | 91.40M | 90.10M | 98.40M | 106.50M | 106.50M | 107.40M | 125.40M | 126.10M | ||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 70.24M | 70.78M | 71.62M | 72.09M | 72.35M | 72.90M | 73.10M | 74.50M | 74.80M | 75.50M | 90.90M | 91.30M | 91.50M | 92.20M | 105.90M | 106.40M | 107.10M | 125.30M | 125.50M | 127.00M | ||||||||||||||||||
| EBITDA | -78.14M | 281.02M | -67.00M | -69.00M | -70.00M | -74.00M | -86.00M | -83.00M | -80.00M | -91.00M | -16.00M | -106.00M | -105.00M | -103.00M | -122.00M | -8.00M | -142.00M | -114.00M | -134.00M | -96.00M | ||||||||||||||||||
| Interest ExpensesInt Expense | 1.00M | 1.00M | 1.00M | 2.00M | 1.00M | 2.00M | 3.00M | 2.00M | 3.00M | 3.00M | ||||||||||||||||||||||||||||
| Tax Rate | 0.71% | -1.49% | -2.56% | -1.35% | -2.90% | -1.25% | -1.08% |